Perivascular epithelioid cell tumour and investigation of genetic susceptibility.
Negin SadeghiSarah Louise SmythStephen DamatoHooman Soleymani MajdPublished in: BMJ case reports (2022)
A patient in her 60s was referred to be investigated for an incidental large uterus with a history of renal cell carcinoma and melanoma. Uterine biopsy revealed features of perivascular epithelioid cell tumours (PEComas) and she underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy. Final histology confirmed PEComa with malignant features. Genomic studies did not reveal any deleterious germline variants; however, in view of her history, she is now under a 6-month follow-up with gynaecology-oncology. PEComas are rare tumours associated with tuberous sclerosis and melanoma, sharing genetic abnormalities. Gynaecological PEComas usually present with no or non-specific symptoms. Preoperative investigations are often misleading. Final histology and immunohistochemistry have overlapping features with smooth muscle tumours. Although rare, PEComas need to be treated aggressively to minimise the potential risk of spread. There is currently little evidence about further adjuvant treatment and no clear follow-up protocol. However, the literature suggests that the prognosis is generally good.
Keyphrases
- single cell
- smooth muscle
- copy number
- genome wide
- renal cell carcinoma
- cell therapy
- systematic review
- case report
- early stage
- patients undergoing
- randomized controlled trial
- dna methylation
- stem cells
- dna repair
- physical activity
- ultrasound guided
- bone marrow
- dna damage
- high resolution
- fine needle aspiration
- single molecule